POSTER SESSION EGCC2024
Epidemiology, screening and prevention
1) Abstract 52
CANCER RISK IN GASTRO-DUODENAL PERFORATIONS, EXPERIENCE FROM A RURAL AREA IN ITALY
Mattei M.S.*[1], Antolino L.[2], Brighi M.[3], Schirripa M.[4], Ranalli T.[5], Bovino A.[6], Giannotti D.[3], Goglia A.[6], Zampaletta C.[7], Santoro R.[3]
[1]ASL Viterbo, UOC Chirurgia Generale Oncologica e d’Urgenza, Viterbo, Italy PhD in training, PhD School in Traslational Medicine and Oncology, Department of Medical and Surgical Sciences and Translational Medicine, Faculty of Medicine and Psycology, Sapien, [2]SICO ETS – Società Italiana di Chirurgia Oncologica – ESSO affiliated, Fellowship in Surgical Oncology, Roma, Italy ASL Viterbo, UOC Chirurgia Generale Oncologica e d’Urgenza, Viterbo, Italy. ~ Rome ~ Italy, [3]ASL Viterbo, UOC Chirurgia Generale Oncologica e d’Urgenza, Viterbo, Italy. ~ Viterbo ~ Italy, [4]ASL Viterbo, UOC Oncologia e rete oncologica, Viterbo, Italy. ~ Viterbo ~ Italy, [5]ASL Viterbo, UOC Anatomia Patologica e Istopatologia, Viterbo, Italy. ~ Viterbo ~ Italy, [6]~ Viterbo ~ Italy, [7]ASL Viterbo, UOC Gastroenterologia ed Endoscopia Digestiva, Viterbo, Italy. ~ Viterbo ~ Italy
Epidemiology, screening and prevention
2) Abstract 64
VENOUS THROMBOEMBOLISM INCIDENCE AND ASSOCIATION WITH OVERALL SURVIVAL IN GASTRIC CANCER: A FINNISH NATIONWIDE REGISTER STUDY
Aaltonen P.[1], Mustonen H.[1], Puolakkainen P.[1], Haglund C.[1], Peltola K.[2], Carpén O.[3], Seppänen H.*[1]
[1]Department of Surgery, Translational Cancer Medicine Research Program, iCAN Digital Precision Cancer Medicine Flagship, Faculty of Medicine, University of Helsinki and Helsinki University Hospital ~ Helsinki ~ Finland, [2]Comprehensive Cancer Center, University of Helsinki and Helsinki University Hospital ~ Helsinki ~ Finland, [3]Medicum, Research Program in Systems Oncology and HUSLAB, University of Helsinki and University of Helsinki ~ Helsinki ~ Finland
Clinical staging in multimodality treatment 3
Clinical staging in multimodality treatment
3) Abstract 30
TOWARDS STANDARDIZATION OF THE STAGING LAPAROSCOPY FOR GASTRIC CANCER: A EUROPEAN DELPHI STUDY
Van Hootegem S.*[1], Guchelaar N.[2], Van Der Sluis K.[3], Triemstra L.[4], Monig S.[5], Rawicz–Pruszynski K.[6], Rosati R.[7], Morgagni P.[8], Erodotou M.[1], Solaini L.[8], De Manzoni G.[9], Polkowski W.[6], Pucetti F.[7], Giacopuzzi S.[9], Gisbertz S.[10], So J.[11], Ruurda J.[4], Van Der Sluis P.[1], Lagarde S.[1], Van Sandick J.[3], Wijnhoven B.[1]
[1]Department of Surgery, Erasmus Medical Center ~ Rotterdam ~ Netherlands, [2]Department of Medical Oncology, Erasmus MC Cancer Institute ~ Rotterdam ~ Netherlands, [3]Department of Surgery, Antoni van Leeuwenhoek ~ Amsterdam ~ Netherlands, [4]Department of Surgery, University Medical Center Utrecht ~ Utrecht ~ Netherlands, [5]Upper-GI-Surgery, University Hospital of Geneva ~ Geneva ~ Switzerland, [6]Department of Surgical Oncology, Medical University of Lublin ~ Lublin ~ Poland, [7]Department of Gastrointestinal Surgery, IRCCS San Raffaele Hospital ~ Milan ~ Italy, [8]Department of General Surgery, Morgagni-Pierantoni Hospital ~ Forli ~ Italy, [9]Upper G.I. Surgery Division, University of Verona ~ Verona ~ Italy, [10]Department of Surgery, Amsterdam UMC location University of Amsterdam ~ Amsterdam ~ Netherlands, [11]Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore ~ Singapore ~ Singapore
Biomarkers in clinical staging 4
Biomarkers in clinical staging
4) Abstract 61
ELEVATED SERUM CA19-9 AND CEA IN ISOLATION DO NOT PREDICT RECURRENT GASTRIC ADENOCARCINOMA AFTER ELECTIVE RESECTION
Patel N., Al–Hasan Y., Patel P.*, Bhogal R., Chaudry M.A., Allum W., Kumar S.
The Royal Marsden NHS Foundation Trust ~ London ~ United Kingdom
Clinical impact of different histotypes 5
Clinical impact of different histotypes
5) Abstract 42
ONCOLOGICAL OUTCOMES AFTER IVOR LEWIS ESOPHAGECTOMY FOR ESOPHAGOGASTRIC SIGNET RING CELL CARCINOMA: A SINGLE-CENTER COMPARATIVE ANALYSIS
Carresi A.*[1], Puccetti F.[1], Mezzomo S.[2], Battaglia S.[1], Albarello L.[1], Elmore U.[1], Rosati R.[1]
[1]IRCCS San Raffaele Hospital ~ Milan ~ Italy, [2]Vita-Salute San Raffaele University ~ Milan ~ Italy
Clinical impact of different histotypes
6) Abstract 62
QUALITY OF LIFE AFTER MAJOR SURGICAL RESECTION FOR GASTRIC/GASTRO-OESOPHAGEAL JUNCTION CANCER: RESULTS FROM A TERTIARY CANCER CENTRE USING EORTC QUESTIONNAIRES
Al–Hasan Y.*, Patel N., Patel P., Bhogal R., Chaudry M.A., Allum W., Kumar S.
The Royal Marsden NHS Foundation Trust ~ London ~ United Kingdom
High technology in gastric cancer diagnosis and treatment 6
High technology in gastric cancer diagnosis and treatment
7) Abstract 1
ROBOTIC SURGERY FOR GASTRIC CANCER IN ELDERLY PATIENTS: EXPERIENCE OF A REFERRAL CENTER
Fortuna L.*, Staderini F., Coratti F., Cianchi F.
Digestive Surgery Unit, Careggi University Hospital ~ Florence ~ Italy
High technology in gastric cancer diagnosis and treatment
8) Abstract 8
EASTERN LAPAROSCOPIC SETTING FOR DISTAL GASTRECTOMY IN A WESTERN CENTER: CAN SIDE LAPAROSCOPY INFLUENCE OUR RESULTS?
Viganò J.*[1], Peri A.[1], Ghaly A.[2], Dagnoni A.[1], Fugazzola P.[1], Di Gioia G.[2], Payola M.[2], Stabile A.[2], Ansaloni L.[1]
[1]Chirurgia Generale, Fondazione IRCCS Policlinico San Matteo ~ Pavia ~ Italy, [2]Scuola di Specialità Chirurgia Generale, Università degli Studi di Pavia ~ Pavia ~ Italy
High technology in gastric cancer diagnosis and treatment
9) Abstract 11
WAYS TO IMPROVE THE RESULTS OF TOTAL GASTRECTOMY WITH JEJUNOGASTROPLASTY IN ACUTE BLEEDING GASTRIC CANCER
Shepetko E.*[1], Burburska S.[2], Novgorodskiy I.[3], Yefremov V.[3], Yasna A.[1]
[1]Kyiv Medical University ~ Kyiv ~ Ukraine, [2]Laboratory of Biomedical Engineering of the Institute of Traumatology and Orthopedics of the National Academy of Medical Sciences of Ukraine ~ Kyiv ~ Ukraine, [3]Innovative Surgical Center Adonis – Lab SP ~ Kyiv ~ Ukraine
High technology in gastric cancer diagnosis and treatment
10) Abstract 12
ROBOTIC GASTRECTOMY FOR GASTRIC CANCER, HAVE ALL QUESTIONS BEEN ASWERED? A PRELIMINAR COMPARISON WITH A HISTORICAL LAPAROSCOPIC COHORT IN A MINIMALLY INVASIVE-ORIENTED INSTITUTION
Lombardi P.M.*, Gualtierotti M., De Martini P., Nicastro V., Marin J., Grimaldi S., Ferrari G.
Minimally Invasive Surgical Oncology Unit – Niguarda Cancer Center, Niguarda Hospital, Milan, Italy ~ Milan ~ Italy
High technology in gastric cancer diagnosis and treatment
11) Abstract 40
HYPERSPECTRAL TECHNOLOGY: AN INNOVATIVE TOOL THAT MAY CHANGE INTRAOPERATIVE STRATEGY AND HELP FOR PREVENTION OF ESO-GASTRIC ANASTOMOSIS LEAKAGE DURING ESOPHAGECTOMY.
Bonino M.A.*, Jung M.K., Chevallay M., Mönig S.P.
Hôpitaux Universitaires de Genève ~ Geneva ~ Switzerland
High technology in gastric cancer diagnosis and treatment
12) Abstract 56
SURGICAL TREATMENT OF GASTRIC CANCER: A SINGLE ONCOLOGICAL CENTRE EXPERIENCE
Vitale I., Buscemi S., Vitale F., Frazzetta G., Picciurro A., Martorana M., Maffongelli A., Marchesa P.*
Ospedale Civico di Palermo ~ Italy ~ Italy
Treatment of early forms 7
Treatment of early forms
13) Abstract 59
ASSESSMENT OF QUALITY OF LIFE AFTER TOTAL GASTRECTOMY IN CDH1 VARIANT CARRIERS
Aaltonen G., Louhimo J.*, Juuti A., Kokkola A.
Helsinki University Hospital ~ Helsinki ~ Finland
Treatment of clinical stage I/II 8
Treatment of clinical stage I/II
14) Abstract 24
THE EFFECT OF MODIFIED ROUX-N-Y ANASTOMOSIS TECHNIQUES ON DIABETES REMISSION IN GASTRIC CANCER PATIENTS WITH TYPE 2 DIABETES
Ünal A.E.*, Çulcu S., GÖkten G., Tekes F., Altinsoy E., Tamam S., Demirci S.
ankara university faculty of medicine ~ ANKARA ~ Turkey
Treatment of clinical stage I/II
15) Abstract 53
INITIAL EXPERIENCE WITH LIMITED GASTRIC RESECTION AND NODAL BASIN LYMPHADENECTOMY GUIDED BY FLUORESCENCE FOR EARLY GASTRIC CANCER IN A WESTERN CENTER
Bonafede M.*, Celotti A., Quarti L.M., Totaro L., Dendena A., Benzoni I., Turco N., Noventa C., Crotti G., Baiocchi G.L.
asst cremona ~ cremona ~ Italy
Locally-advanced gastric cancer 9
Locally-advanced gastric cancer
16) Abstract 3
THE LYMPHADENECTOMY SURVIVAL VALUE IN A SINGLE WESTERN POPULATION AFFECTED BY GASTRIC ADENOCARCINOMA
Natalizi N.*, Di Schiena F., Grazioasi L., Donini A.
University of Perugia ~ Perugia ~ Italy
Locally-advanced gastric cancer
17) Abstract 16
THE IMPACT OF THE NUMBER OF LYMPH NODES REMOVED DURING D2 DISSECTION ON SURVIVAL IN GASTRIC CANCER
Ilhan E.*[1], Ureyen O.[1], Inci E.[2], Simsek H.[3], Hamzacelebioglu M.[2], Argon A.[1]
[1]UNIVERSITY OF HEALTH SCIENCES, IZMIR FACULTY OF MEDICINE ~ IZMIR ~ Turkey, [2]IZMIR CITY HOSPITAL, GENERAL SURGERY ~ IZMIR ~ Turkey, [3]DOKUZ EYLUL UNIVERSITY FACULTY OF MEDICINE ~ IZMIR ~ Turkey
Locally-advanced gastric cancer
Locally-advanced gastric cancer
18) Abstract 18
ROLE OF POSITIVE LOCOREGIONAL LYMPH NODES AFTER CURATIVE GASTRECTOMY AS PREDICTORS OF PERITONEAL RECURRENCE: A SINGLE WESTERN CENTRE RETROSPECTIVE ANALYSIS
Di Schiena F.*, Natalizi N., Longaroni M., Graziosi L., Donini A.
Università degli Studi di Perugia ~ Perugia ~ Italy
Locally-advanced gastric cancer
19) Abstract 23
COMPLIANCE WITH POSTOPERATIVE CHEMOTHERAPY IN PATIENTS UNDERGOING SURGERY FOR LOCALLY ADVANCED GASTRIC CANCER: SINGLE CENTER RETROSPECTIVE ANALYSIS
Nicastro V.*, Grimaldi S., Marin J., De Martini P., Gualtierotti M., Lombardi P.M., Ferrari G.
Division of Minimally-Invasive Surgical Oncology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda ~ Milan ~ Italy
Locally-advanced gastric cancer
20) Abstract 34
OPTIMIZING POSTOPERATIVE OUTCOMES AFTER STANDARDIZED LAPAROSCOPIC GASTRIC CANCER SURGERY
Belev N.*, Krastev P.
UMBAL-Eurohospital-Plovdiv, Department of Propedevtic of Surgical Desease, Faculty of Medicine, Medical University-Plovdiv ~ Plovdiv ~ Bulgaria
Locally-advanced gastric cancer
21) Abstract 35
LAPAROSCOPIC SURGERY IN ADVANCED GASTRIC CANCER T2-4 N1-3M1P1(POSITIVE CYTOLOGY) COMBINED WITH HIGH-PRESSURE AEROSOL CHEMOTHERAPY
Belev N.*, Byankov A., Krastev P.
UMHAT-Eurohospital Plovdiv1, Department of Propedevtic of Surgical Desease, Faculty of Medicine, Medical University-Plovdiv2. ~ Plovdiv ~ Bulgaria
Locally-advanced gastric cancer
22) Abstract 45
RANDOMIZED, MULTICENTER GASTRIC CHIMERA TRIAL – PROPHYLACTIC HIPEC AS AN ADJUNCT TO FLOT CHEMOTHERAPY IN ADVANCED GASTRIC CANCER – SAFETY ANALYSIS
Kolodziejczyk P.*[1], Sierzega M.[1], Szczepanik A.[2], Pach R.[1], Zegarski W.[3], Polkowski W.[4], Bebenek M.[5], Godula D.[1], Gwizdak P.[1], Richter P.[1]
[1]First Department of Surgery, Jagiellonian University ~ Krakow ~ Poland, [2]Third Department of Surgery, Jagiellonian University ~ Krakow ~ Poland, [3]Department of Surgical Oncology, Nicolaus Copernicus University ~ Torun ~ Poland, [4]Department of Surgical Oncology, Medical University of Lublin ~ Lublin ~ Poland, [5]Department of Surgery, Lower Silesian Oncological Centre ~ Wroclaw ~ Poland
Locally-advanced gastric cancer
23) Abstract 67
SARCOPENIA EFFECTS ON ONCOLOGICAL AND SURGICAL OUTCOMES AFTER GASTRECTOMY
Sbacco V.*[1], Puccetti F.[3], Palumbo D.[4], Ortu G.J.[4], Campisi A.[4], Mazza E.[5], De Cobelli F*. Elmore U.[2], Rosati R.[2]
[1]Department of Gastrointestinal Surgery, San Raffaele Research Hospital, Milan, Italy. Department of Medical and Surgical Sciences and Translational Medicine, Sant’Andrea Hospital, Sapienza University of Rome, Rome, Italy ~ Milan ~ Italy, [2]Department of Gastrointestinal Surgery, San Raffaele Research Hospital, Milan, Italy ~ Milan ~ Italy, [3]Department of Gastrointestinal Surgery, San Raffaele Research Hospital, Milan, Italy. ~ Milan ~ Italy, [4]Department of Radiology, San Raffaele Research Hospital, Milan, Italy ~ Milan ~ Italy, [5]Department of Medical Oncology, San Raffaele Research Hospital,Comprehensive Cancer Center, Milan, Italy ~ Milano ~ Italy
Department of Radiology, San Raffaele Research Hospital, Milan, Italy”
Treatment of patients “unfit” for multimodal approach 10
Treatment of patients “unfit” for multimodal approach
24) Abstract 2
PROGNOSTIC FACTORS AFFECTING SURVIVAL IN ELDERLY PATIENTS AFFECTED BY GASTRIC CANCER
Longaroni M.*, Natalizi N., Di Schiena F., Graziosi L., Donini A.
University of Perugia ~ Perugia ~ Italy
Post-operative management 11
Post-operative management
25) Abstract 29
IMPACT OF POSTOPERATIVE COMPLICATIONS ON CLINICAL ADVERSE OUTCOMES AFTER GASTRECTOMY FOR CANCER: A GLOBAL MULTICENTRE ANALYSIS.
Van Hootegem S.*[1], Van Der Linde M.[2], Schneider M.[3], Kim J.[4], Berlth F.[5], Sugita Y.[6], Grimminger P.[5], Baiocchi G.L.[7], De Manzoni G.[8], Bencivenga M.[8], Gisbertz S.[9], Nunobe S.[6], Yang H.[4], Gutschow C.[3], Lingsma H.[2], Wijnhoven B.[1]
[1]Department of Surgery, Erasmus Medical Center ~ Rotterdam ~ Netherlands, [2]Department of Public Health, Erasmus Medical Center ~ Rotterdam ~ Netherlands, [3]Department of Surgery & Transplantation, University Hospital Zürich ~ Zurich ~ Switzerland, [4]Department of Surgery, Seoul National University Cancer Hospital ~ Seoul ~ Korea, Democratic People’s Republic of, [5]Department of General-, Visceral- and Transplant Surgery, University Medical Center Mainz, ~ Mainz ~ Germany, [6]Department of Gastroenterological Surgery, Cancer Institute Hospital of the Japanese Foundation for Cancer Research ~ Tokyo ~ Japan, [7]Department of Surgery, University Hospital of Brescia ~ Brescia ~ Italy, [8]Department of Surgery, University Hospital of Verona ~ Verona ~ Italy, [9]Department of Surgery, Amsterdam UMC, University of Amsterdam ~ Amsterdam ~ Netherlands
Post-operative management
26) Abstract 60
THE EFFECT OF BODY MASS INDEX TO POST-OPERATIVE COMPLICATIONS IN PATIENTS OPERATED FOR GASTRIC ADENOCARCINOMA – POPULATION-BASED NATIONWIDE COHORT STUDY IN FINLAND
Jalkanen A.*[1], Kauppila J.[2], Louhimo J.[1], Puolakkainen P.[1], Kokkola A.[1]
[1]University of Helsinki and Helsinki University Hospital ~ Helsinki ~ Finland, [2]Department of Surgery, Oulu University Hospital and University of Oulu ~ Oulu ~ Finland
Post-operative management
27) Abstract 63
EVALUATING THE IMPACT OF LIMITED LYMPHADENECTOMY (<16 NODES) ON THE ACCURACY OF PN0 CLASSIFICATION IN GASTRIC CANCER: A SIMULATION STUDY.
Matos Da Costa P.*[1], Antunes C.[2], Lara Santos L.[3]
[1]Universidade de Lisboa, Faculdade de Medicina ~ Lisboa ~ Portugal, [2]Universidade de Lisboa, Instituto Superior Técnico, Department of Computer Science and Engineering, ~ Lisboa ~ Portugal, [3]Instituto Português de Oncologia-Porto, Surgical Oncology Department ~ Porto ~ Portugal
Post-operative management
28) Abstract 73
EVALUATION OF THE PROGNOSTIC IMPACT OF PERIOPERATIVE BLOOD TRANSFUSION IN PATIENTS UNDERGOING CURATIVE GASTRECTOMY FOR STAGE I-III GASTRIC CANCER
Andreucci E.*, Piccioni S., Sandini M., Carbone L., Poto G.E., Catozzi L., Mainenti R., Guarracino A., Marchini E., Roviello F.
unit of general surgery and surgical oncology, department of medicine, surgery and neurosciences, university of Siena, policlinico ” Le Scotte”, Siena, Italy ~ Siena ~ Italy
Oligometastatic gastric cancer 12
Oligometastatic gastric cancer
29) Abstract 21
PERITONEAL OLIGOMETASTATIC GASTRIC CANCER: CAN WE REALLY TALK ABOUT IT? – DATA FROM THE ITALIAN MULTICENTRIC REGISTRY “METAGASTRO”
Ministrini S.*
ASST Spedali Civili Brescia ~ Brescia ~ Italy
Bidirectional treatments, conversion surgery 13
Bidirectional treatments, conversion surgery
30) Abstract 43
NEOADJUVANT INTRAPERITONEAL CHEMOTHERAPY IN GASTRIC CANCER WITH HIGH-RISK FOR PERITONEAL METASTASES: SYSTEMATIC REVIEW OF LITERATURE AND STUDY PROPOSAL (PIPER-TRIAL)
Battaglia S.*[1], Noordman B.[2], Keywani K.[3], Derks S.[3], Grootjans J.[3], Van Grieken N.[3], Van Laarhoven H.[3], Van Berge Henegouwen M.[3], Gisbertz S.[3]
[1]IRCCS San Raffaele Hospital ~ Milan ~ Italy, [2]Erasmus MC, University Medical Center Rotterdam ~ Rotterdam ~ Netherlands, [3]Amsterdam UMC, University of Amsterdam ~ Amsterdam ~ Netherlands
Bidirectional treatments, conversion surgery
31) Abstract 49
A CASE OF METASTATIC GASTRIC CANCER WITH A GREAT RESPONSE TO STANDARD CHEMOTHERAPY
Filippini F.*, Alloggio M., Sacco M., Tedone F., De Manzoni G., Bencivenga M.
Department of General and Upper GI Surgery, University of Verona ~ Verona ~ Italy
Bidirectional treatments, conversion surgery
32) Abstract 65
PRESSURIZED INTRAPERITONEAL AEROSOL CHEMOTHERAPY IN GASTRIC ADENOCARCINOMA WITH PERITONEAL METASTASES CAN LEAD TO TOTAL GASTRECTOMY WITH CURATIVE INTENT: REPORT OF A CASE
Racine M.*, Ris F., Koessler T., Amram M., Toso C., Labidi–Galy I., Mönig S.
Geneva University Hospital ~ Geneva ~ Switzerland
Esophagogastric junction – early stages 14
Esophagogastric junction – early stages
33) Abstract 68
IMPACT OF OBESITY ON POSTOPERATIVE OUTCOMES IN PATIENTS UNDERGOING ESOPHAGECTOMY FOR RESECTABLE GASTRO-ESOPHAGEAL CANCER
Patel P.*, Patel N., Doyle J., Alhasan Y., Bhogal R., Chaudry A., Allum W., Kumar S.
The Royal Marsden NHS Foundation Trust ~ London ~ United Kingdom
Esophagogastric junction – advanced stages 15
Esophagogastric junction – advanced stages
34) Abstract 32
ESOPHAGOGASTRIC JUNCTION SIEWERT TYPE II TUMORS, A CHALLENGE FOR THE SURGEON: COMPARISON OF RESULTS OF TRANSHIATAL EXTENDED GASTRECTOMY VS. IVOR LEWIS ESOPHAGECTOMY IN A HIGH-VOLUME CENTER
Riccio F.*, Pierobon E.S., Moletta L., Sciuto M.E., De Pasqual A.L., Zuin I.S., Pittacolo M., Zanchettin G., Capovilla G., Salvador R., Provenzano L., Valmasoni M.
1st Surgical Unit, Padova University Hospital ~ Padova ~ Italy
Targeted therapies, immunotherapy and their combination with multimodal approach 18
Targeted therapies, immunotherapy and their combination with multimodal approach
35) Abstract 58
GASTRIC SURGERY AFTER IMMUNOTHERAPY
Benzoni I.*[1], Bonomi M.[2], Grizzi G.[2], Verdelli G.[3], Celotti A.[1], Quarti L.M.[1], Totaro L.[1], Laurenza C.[4], Bonafede M.[1], Dendena A.[3], Grassia R.[4], Baiocchi G.L.[3]
[1]Department of Surgery, ASST Cremona Italy ~ Cremona ~ Italy, [2]Department of Medical Oncology, ASST Cremona Italy ~ Cremona ~ Italy, [3]Department of Clinical and Experimental Sciences, University of Brescia, Italy ~ Brescia ~ Italy, [4]Department of Endoscopy, ASST Cremona, Italy ~ Cremona ~ Italy
Nutritional support, pre-habilitation, palliative therapies 19
Nutritional support, pre-habilitation, palliative therapies
36) Abstract 20
CHALLENGES IN THE MANAGEMENT OF GASTRIC CANCER AMONG THE ELDERLY: THE IMPACT OF AGE ON LONG-TERM SURVIVAL FOLLOWING CURATIVE GASTRECTOMY VS PALLIATIVE SURGERY
Di Schiena F.*, Longaroni M., Natalizi N., Graziosi L., Donini A.
Università degli Studi di Perugia ~ Perugia ~ Italy
Nutritional support, pre-habilitation, palliative therapies
37) Abstract 38
ENHANCED RECOVERY PROTOCOLS IN GASTRECTOMY FOR GASTRIC CANCER: EVALUATING THE IMPACT OF FRAILTY
Solaini L.*[1], Filippini F.[2], Treppiedi E.[3], Realis Luc M.[4], Milone M.[5], Zucchini V.[1], Morgagni P.[6], De Pascale S.[4], De Palma G.D.[5], Elmore U.[3], Giacopuzzi S.[2], Ercolani G.[1]
[1]University of Bologna, Morgagni-Pierantoni Hospital. ~ Forli ~ Italy, [2]University of Verona ~ Verona ~ Italy, [3]Department of Gastrointestinal Surgery, IRCCS San Raffaele Scientific Institute ~ Milan ~ Italy, [4]Digestive Surgery, European Institute of Oncology IRCCS ~ Milan ~ Italy, [5]Department of Clinical Medicine and Surgery, “Federico II” University of Naples ~ Naples ~ Italy, [6]Morgagni-Pierantoni hospital ~ Forli ~ Italy
Nutritional support, pre-habilitation, palliative therapies
38) Abstract 44
NUTRITIONAL INTERVENTION IN A GASTRIC CANCER PATIENT UNDERWENT GASTRECTOMY: A CASE REPORT
Daniele A.*, Brunetti O., Schiavone S., Zito A.F., Garrisi V.M., Quaresmini D., Costa A., Loconte T., Paciolla C., Sciortino G., De Luca R.
IRCCS Istituto Tumori “Giovanni Paolo II” ~ Bari ~ Italy